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Abstract
The human subgroup C adenovirus (Ad) protein named adenovirus death protein (ADP) (previously named E3-11.6K) is synthesized at
very late stages of infection when it mediates efficient lysis of cells and release of adenovirus to infect other cells. ADP is an integral
membrane N-linked, O-linked palmitoylated glycoprotein of 101 amino acids (aa) that localizes to the nuclear membrane, endoplasmic
reticulum (ER), and Golgi. It has a single membrane spanning region (roughly aa 40–60) and is oriented with aa 1–40 in the lumen and
aa 61–101 in the nucleoplasm and cytoplasm. Using aa 61–101 of Ad2 ADP as bait in a yeast two-hybrid screen, we isolated a cDNA for
a 211-aa protein that initially was not in the database but has now been published by others with the names human MAD2B, MAD2L2, and
REV7. ADP binds strongly to human MAD2B not only in yeast but also in GST pull-down experiments and in coimmunoprecipitations of
ADP and MAD2B synthesized in vitro or in vivo. ADP mutants with deletions throughout the bait region do not interact with human
MAD2B, whereas a Pro69Pro70 to Ala69Ala70 mutant in the “basic-proline” domain of ADP does interact. Northern blot analyses indicate
that human MAD2B is expressed ubiquitously. Human MAD2B is about 25% identical to human MAD2, a spindle assembly checkpoint
protein. Two human A549 cell lines were made that constitutively overexpress MAD2B. Wild-type adenovirus lyses these cells significantly
more slowly than it lyses parental A549 cells, raising the possibility that ADP and MAD2B act in opposition and suggesting that the
ADP–MAD2B interaction is biologically relevant.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Adenovirus (Ad) infections in cell culture proceed in
multiple programmed steps (reviewed by Shenk, 2001). The
virion interacts with a specific cellular receptor (CAR) and
is internalized via v3 and v5 integrins into endosomes.
The virion is extruded from endosomes (shedding proteins),
and the genome nucleoprotein complex passes through nu-
clear pores into the nucleus. The first Ad genes expressed
are the E1A immediate early genes. The E1A proteins de-
regulate the cell cycle such that the cell becomes a good
host for virus replication, and they induce expression of the
genes in the delayed early E1B, E2, E3, and E4 transcription
units. Approximately 20 early proteins function to deregu-
late the cell cycle, induce and repress a variety of cellular
genes, alter the activity of existing cellular proteins includ-
ing transcription factors, inhibit cellular apoptosis, induce
synthesis of viral DNA, and protect the cell against attack
by cell-mediated immunity. At the late stage of infection,
which follows the initiation of viral DNA replication at
about 7 h postinfection (hpi), late proteins are expressed,
most of them from the major late transcription unit. Most
late proteins are structural components of the virion or
proteins required for processing of late proteins and for
virion assembly. Virions begin to assemble in the cell nu-
cleus at roughly 20 hpi, and they continue to accumulate for
another day or so.
As virions accumulate, the cells undergo a process that
ultimately leads to cell lysis and the release of a portion of
the virus particles from the cell. This lysis is mediated in
large part by a protein named adenovirus death protein
(ADP) (Tollefson et al., 1996a, 1996b). Ad mutants that
lack functional ADP have small plaques that are slow to
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develop, and such mutants are much slower than wild-type
Ad in lysing cells (Tollefson et al., 1996a, 1996b). On the
other hand, Ad mutants that overexpress ADP have large
plaques and they are more proficient in lysing cells and
spreading to other cells (Doronin et al., 2000, 2001, 2003).
ADP is predicted to be composed of 101 amino acids and
was originally named E3-11.6K (11,600 kDa) (Wold et al.,
1984). The adp gene is located in the E3 transcription unit,
and ADP is expressed in low amounts from two minor
spliced mRNAs transcribed from the E3 promoter at early
stages of infection (Wold et al., 1984; Cladaras and Wold,
1985; Bhat et al., 1985). It is not known what function is
exerted by ADP at early stages of infection. ADP is ex-
pressed in large amounts at late stages of infection, very
likely from mRNA derived from the major late transcription
unit (Tollefson et al., 1992). This putative mRNA for ADP
has the major late tripartite leader spliced to an exon known
as the y-leader which is in turn spliced to the coding se-
quences for ADP (Tollefson et al., 1992). As indicated by an
interval labeling experiment, the rate of ADP synthesis
begins to increase dramatically at 20–24 hpi, and this rate
continues to increase beyond 30 hpi (Tollefson et al., 1992).
This pattern of synthesis is consistent with the proposed role
for ADP synthesis in mediating cell lysis (Tollefson et al.,
1996a, 1996b).
ADP is found associated with membranes in cell frac-
tionation experiments (Scaria et al., 1992). As judged by its
predicted amino acid sequence, ADP is a type III (Nendo/
Cexo) integral membrane glycoprotein with an internal un-
cleaved signal–anchor sequence, an NH2-terminal lumenal
domain, and a COOH-terminal nonlumenal domain (Fig.
1A) (Scaria et al., 1992). The lumenal domain has a single
site for N-linked glycosylation, and this site is modified with
complex oligosaccharides (Scaria et al., 1992). Also, one or
more sites in the lumenal domain are modified with O-
linked sugars (Tollefson et al., 2003). ADP is also palmi-
toylated at two cysteine residues (C60C61) located at the
COOH-terminal boundary of the putative single-anchor do-
main (Fig. 1A) (Hausmann et al., 1998).
The molecular mechanisms by which ADP promotes cell
lysis are not known. Immunofluorescence indicates that
ADP is initially localized in the ER where it is synthesized
and also in the Golgi apparatus where it is glycosylated
(Scaria et al., 1992). However, the protein appears to accu-
mulate in the nuclear membrane and Golgi (Scaria et al.,
1992). Structure–function analyses suggest that ADP must
reside in the nuclear membrane in order to exert its lytic
function (Tollefson et al., 2003).
As a means to learn more about the function of ADP, we
have conducted a yeast two-hybrid analysis using the
Fig. 1. (A) Schematic representation of Ad2 ADP. The hatched region indicates the signal–anchor (transmembrane) domain. CHO refers to Asn-linked
glycosylation. BP refers to a basic-proline rich region. Positions of the palmitoylated cysteine residues are depicted by CC. (B) Amino acid sequence of the
Ad2 ADP C-terminal cytoplasmic/nucleoplasmic domain that was used as the bait in the yeast two-hybrid screens. (C) Summary of Ad2 ADP C-terminal
domain mutants analyzed for their ability to interact with human MAD2B. () Indicates positive interaction, () indicates no interaction.
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COOH-terminal 40 amino acids (aa) of ADP as bait (Fig.
1B). Here we report that a cellular protein named human
MAD2B interacts with ADP and that it appears to oppose
the lytic function of ADP.
Results
Identification of MAD2B as a protein that interacts with
ADP in the yeast two-hybrid system
To gain insight into the molecular mechanism by which
ADP promotes cell lysis, we performed yeast two-hybrid
screens to identify ADP-interacting cellular partners from
both HeLa and human fetal brain cDNA libraries. The bait
plasmid was constructed by fusing the ADP putative cyto-
plasmic domain, aa 61–101, to the Gal4 DNA-binding do-
main; this bait is named ADPc. The Gal4 portion of the
fusion protein has a nuclear localization signal. Approxi-
mately 2  105 independent clones were screened; one
positive clone was obtained from each library as judged by
growth on minimal medium lacking Leu, Trp, and His and
by a positive reaction for -galactosidase activity using a
colony filter assay. An example of an X-gal filter assay for
the clone from the HeLa cDNA library is shown in Fig. 2,
filter Section 1. The ADPc bait did not interact with an
irrelevant prey, pGADG4 (Fig. 2, Section 6). The two
cDNA clones from the HeLa and fetal brain libraries con-
tained the identical entire coding region with varying
lengths of upstream sequence. The cloned sequence initially
was not in the database but has now been published with the
names MAD2B, MAD2L2, and hREV7 (Cahill et al., 1999;
Nelson et al., 1999; Pfleger et al., 2001; Murakumo et al.,
2000). The complete cDNA of MAD2B contains a 633-base
pair open reading frame (ORF) with a predicted protein of
211 aa and an expected molecular mass of 24 kDa. Se-
quence analysis of MAD2B revealed 23–25% identity and
48–54% similarity with human MAD2 depending on the
software program. Human MAD2 is one of the spindle
assembly checkpoint proteins.
To examine further the specificity of the ADPc–MAD2B
interaction, the binding of ADP to various other baits was
tested. In the experiment in Fig. 2, Section 6, ADPc did not
interact with pGADG4, a plasmid that expresses only the
Gal4 DNA binding domain. In another experiment, ADPc
did not bind to prey plasmids containing ORFs for the
apoptosis-inhibiting proteins E1B-19K and BCL-2; the
apoptosis-promoting proteins BNIP1, BNIP2, and BAX, or
human MAD2 (Table 1). ADP baits containing the trans-
membrane domain plus the cytoplasmic domain (aa 41–
101) or the entire ADP ORF (wild-type) did not interact
with MAD2B (Table 1), possibly because baits that contain
large hydrophobic regions are often not synthesized well in
yeast. Fig. 2 and Table 1 show yeast two-hybrid data with
various other baits and preys that were analyzed in the same
experiments in which the ADP baits were evaluated. Inter-
actions that were known to occur did occur (e.g., Boyd et
al., 1994; reviewed by Wold and Chinnadurai, 2000), such
as p53 and SV40 T-antigen (Fig. 2, Section 4); E1B-19K
with BNIP1 and BNIP2 (Table 1); and BCL-2 with BCL-2,
BNIP1, BNIP2, and BAX (Table 1). Interestingly, MAD2B
interacted with itself (Fig. 2 and Table 1). These various
positive and negative controls lend support to the proposal
that the interaction between ADPc and MAD2B is specific.
As an initial attempt to identify the aa sequences in the
ADPc bait that interact with MAD2B, the interaction was
tested using ADPc baits containing deletions throughout the
Fig. 2. Analysis of the interaction of MAD2B with the Ad2 ADP C-
terminus by the yeast two-hybrid system. The yeast strain Y153 was
cotransformed with the indicated plasmids; plated on medium lacking
tryptophan, leucine, and histidine; incubated at 30°C for 6 days; and
analyzed by X-gal filter assay. The bait plasmids contain the Gal4 DNA-
binding domain; the prey plasmids contain the Gal4 activation domain.
Table 1
Yeast two-hybrid assay
Bait vector Prey vector
Vector MAD2B E1B-19K BCL-2 BNIP1 BNIP2 BAX MAD2
Vector        
ADPc (61–101)        
ADP (41–101)        
ADP (1–101)        
E1B-19K   ND ND   ND ND
BCL2   ND     ND
Lamin C   ND ND ND ND ND ND
MAD2B   ND ND ND ND ND 
Note., positive interaction;  negative interaction; ND, not done.
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cytoplasmic domain. All deletions, namely, 63–70 (aa
63–70 are deleted), 71–94, 76–89, 81–88, 79–101,
failed to interact with the MAD2B prey (Fig. 1C). On the
other hand, a mutant in which Pro69 and Pro70 were both
converted to Ala did react (Fig. 1C); this mutation is in the
“basic-proline” domain of ADP (Figs. 1A and B). These
results provide further evidence for the specificity of the
ADP–MAD2B interaction, and they indicate that most of
the cytoplasmic domain of ADP is required for this inter-
action. We note that there are at least two possible inter-
pretations to the deletion mutant data: first, the sequences
deleted may form direct physical contact with MAD2B;
second, the deletions may affect the tertiary structure of the
cytoplasmic domain such that another portion of the mole-
cule that is involved in direct physical binding can no longer
bind.
In vitro and in vivo interaction of ADP and MAD2B
To test further the interaction between ADP and
MAD2B, a GST “pull-down” assay was performed. Full-
length ADP and the ADP C-terminus aa 61–101, both with
a His6 tag at their NH2-termini, were subjected to in vitro
transcription and translation and labeling with a [35S]me-
thionine/cysteine mixture and then assessed for their ability
to bind to a bacterially purified GST–MAD2B fusion pro-
tein. As expected, both full-length (pR-ADP) and C-termi-
nal (pR-ADPc) ADP bound selectively to GST–MAD2B
(Fig. 3, lanes e and f) but not to GST protein alone (lanes b
and c). We also performed a GST pull-down assay using
extracts from wild-type virus rec700- and ADP-minus mu-
tant dl712-infected KB cells that had been metabolically
labeled. Again, GST–MAD2B pulled down ADP whereas
GST alone did not (data not shown). These GST pull-down
data are consistent with our two-hybrid findings, which
showed that ADP interacts specifically with MAD2B.
To determine whether ADP interacts with MAD2B in
vivo in mammalian cells, a coimmunoprecipitation Western
blot analysis was performed. COS7 cells were cotransfected
with plasmid vectors expressing ADP (pMT2-ADP) or
Myc-tagged MAD2B (pMyc-MAD2B). Lysates from trans-
fected cells were subjected to immunoprecipitation using
anti-ADP polyclonal antibody p87–101 directed against a
peptide corresponding to aa 87–101 in Ad2 ADP. The
immunoprecipitates were separated by SDS–PAGE, blotted
onto a membrane, and probed with anti-Myc antibody to
detect the presence of coimmunoprecipitating Myc-
MAD2B. Myc-MAD2B was clearly detected in ADP im-
munoprecipitates (Fig. 4, top panel, lane a). In the cells
transfected with the empty vector pMT2 instead of plasmid
pMT2-ADP, the anti-ADP antibody did not precipitate
Myc-MAD2B (Fig. 4, top panel, lane b). The ADP antibody
also did not coimmunoprecipitate Myc-MAD2B from cells
that had not been transfected with plasmid pMyc-MAD2B
(Fig. 4, top panel, lanes c and d). A standard Western blot
analysis showed that cells transfected with the pMyc-
MAD2B plasmid had similar amounts of Myc-MAD2B
(Fig. 4, middle panel, lanes a and b). Similar amounts of
ADP were also obtained from cells transfected with pMT2-
ADP plasmid (Fig. 4, bottom panel, lanes a and c).
Additionally, we performed coimmunoprecipitation–
Western blot analysis in the reverse order, i.e., immunopre-
cipitation of FLAG-MAD2B followed by probing the blot
with the antibody to ADP. In the experiment, we cotrans-
fected COS7 cells with plasmid pMT2-ADP expressing
ADP and plasmid pFLAG-MAD2B expressing FLAG-
tagged MAD2B. We used the rabbit polyclonal p87–101
antibody against ADP and a monoclonal antibody against
FLAG. As expected, ADP was abundantly coimmunopre-
cipitated by the anti-FLAG-MAD2B antibody in cotrans-
fected cells (Fig. 5, top panel, lane d), but not in cells that
received either pMT2-ADP alone or pFLAG-MAD2B alone
(Fig. 5, top panel, lanes b and c, respectively). Cells trans-
fected with pMT2-ADP (Fig. 5, lower panel, lanes b and d)
or pMyc-MAD2B (Fig. 5 middle panel, lanes c and d) had
equivalent amounts of ADP or Myc-MAD2B, respectively.
We also conducted an indirect immunofluorescence ex-
periment using a mouse monoclonal antibody to Myc (to
detect Myc-tagged MAD2B) and a rabbit polyclonal anti-
body to ADP in Ad-infected MAD2B-7 and MAD2B-9
cells that stably overexpress MAD2B (see below). Myc-
MAD2B localized exclusively to the cell nucleus, while
ADP was seen in the nuclear membranes as well as other
membranes (data not shown), as reported previously for
ADP (Scaria et al., 1992). Neither protein appeared to affect
the intracellular localization of the other. We do not under-
stand this result given our other findings in this paper. It is
conceivable that ADP localized in the inner membrane with
the COOH-terminal domain extending into the nucleoplasm
could interact with nuclear MAD2B, but we have no direct
data on this point.
In conclusion, ADP and MAD2B coimmunoprecipitated
with each other from extracts of cotransfected cells. These
Fig. 3. The Ad2 ADP C-terminus binds to human MAD2B in vitro. GST
or GST-MAD2B expressed from bacteria were preincubated with gluta-
thione beads and then 35S-labeled full-length ADP (pR-ADP) or C-terminal
ADP (pR-ADPc) with N-terminal His6 tags were added. After incubation,
the beads were washed and bound material was separated by SDS–PAGE
and subjected to PhosphorImager analysis. The 35S-labeled ADP or ADPc
proteins were synthesized by in vitro transcription and translation.
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findings indicate that ADP specifically interacts with
MAD2B in vivo.
MAD2B is widely expressed in tissues
Northern blot analysis of multiple human tissues and cancer
cell lines revealed that MAD2B hybridized to a single band of
1.3 kilobases whose expression was fairly ubiquitous; the
level of MAD2B expression varied among the tissues ana-
lyzed, with the highest level in heart followed by liver, pan-
creas, skeletal muscle, placenta, kidney, brain, and lung (Fig.
6A). In human cancer cell lines, high expression of MAD2B
was detected in lymphoblastic leukemia cells and colorectal
adenocarcinoma cells; low expression was seen in HeLa, lung
carcinoma, and melanoma cell lines (Fig. 6A).
MAD2B antagonizes the cell lysis promoting property of
ADP in wild-type adenovirus-infected A549 cells
To investigate how MAD2B functions in relationship to
the ADP cell lysis-promoting property, two cloned A549
Fig. 4. Ad2 ADP interacts with human MAD2B in vivo. COS7 cells were transiently cotransfected with the indicated plasmids. Immunoprecipitation was performed
with polyclonal anti-ADP p87–101; the resulting immunoprecipitates were run on SDS–PAGE, blotted, and probed with an anti-Myc polyclonal antibody to detect
Myc-MAD2B (upper panel). Expression of Myc-MAD2B (middle panel) and ADP (lower panel) was shown by Western blot. The upper band of ADP represents
ADP with N-linked high-mannose oligosaccharides. The lower band corresponds to a posttranslational proteolytic processing product.
Fig. 5. Ad2 ADP interacts with human MAD2B in vivo. COS7 cells were
transiently transfected with the indicated plasmids. Extracts were subjected
to immunoprecipitation using an anti-Flag monoclonal antibody to immu-
noprecipitate FLAG-tagged MAD2B, and the resulting immunoprecipi-
tates were run on SDS–PAGE, blotted, and probed with the anti-ADP
antibody p87–101 (upper panel). Expression of Flag-MAD2B and ADP
was shown by western blot (middle and lower panels).
Fig. 6. Northern blot analysis of the expression of human MAD2B in
multiple tissues and multiple cancer cell lines. Multiple tissues and cancer
cell lines were probed under high stringency with a 32P-labeled human
MAD2B cDNA probe (A) or actin probe (B).
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cell lines stably expressing Myc-tagged MAD2B were gen-
erated. These lines were named MAD2B Clone 7
(MAD2B-7) and MAD2B Clone 9 (MAD2B-9). The ex-
pression of Myc-MAD2B in these cell lines as well as in
parental A549 cells was examined by immunoblot using a
rabbit polyclonal antiserum raised against MAD2B. A
strong band of Myc-MAD2B was obtained from both cell
lines (Fig. 7, lanes b and c). This band was not apparent with
the parental A549 cell line, but two other minor bands were
seen (Fig. 7, lane a). The lower band may correspond to
endogenous MAD2B, which would be smaller than Myc-
MAD2B and which was also present with the MAD2B-7
and MAD2B-9 cell lines.
The proliferation of the MAD2B-7 and MAD2B-9 cell
lines was compared to that of parental A549 cells. The cells
(2  104) were plated in 35-mm dishes in 1  DMEM
containing 10% fetal bovine serum. At 24-h intervals, cells
from triplicate dishes were trypsinized and the cell numbers
counted. There was little difference in the growth curves
among the three cell lines (data not shown), indicating that
overexpression of Myc-MAD2B did not affect cell prolif-
eration. A potential caveat for this experiment is that Myc-
tagged MAD2B may be nonfunctional; however, the data
described in the next section suggest that the protein is in
fact functional.
To determine whether the Myc-MAD2B affected Ad
replication and in particular the function of ADP, the
MAD2B-7 cell line and its parental A549 cells were in-
fected with wild-type Ad rec700 or with the ADP-minus
mutant pm734.1. At sequential days postinfection, cell via-
bility was assayed by release of lactate dehydrogenase
(LDH) from the cells. As shown in Fig. 8A, A549 parental
cells infected with rec700 (wild type) were lysed (i.e., the
membrane became permeable to release of LDH) more
rapidly and to a greater extent than cells infected with
pm734.1 (ADP mutant); this result, which illustrates the cell
lysis-promoting function of ADP, is consistent with our
previous findings (Tollefson et al., 1996a). With pm734.1-
infected cells, no significant difference in cell lysis was
observed between A549 cells and MAD2B-7 cells. How-
ever, when the MAD2B-7 stable cell line infected with
rec700 was compared with A549 cells infected with rec700,
the MAD2B-7 cells were lysed significantly more slowly
than were A549 cells (Fig. 8A), suggesting that the expres-
sion of MAD2B counteracts the cell lysis-promoting func-
tion of ADP.
The trypan blue exclusion assay was used as another
indicator of cell viability. As shown in Fig. 8B, A549 cells
infected with rec700 were lysed (became permeable to
trypan blue) much more efficiently than cells infected with
pm734.1, again illustrating the cell lysis-promoting property
of ADP and being in accord with earlier results (Tollefson
et al., 1996a). Comparing the MAD2B stable cell line in-
fected with rec700 with A549 cells infected with rec700,
MAD2B-7 cells were lysed much slower than A549 cells. In
Fig. 7. Expression of Myc-tagged MAD2B and endogenous MAD2B in
stably transfected cells. Proteins extracted from parental A549 cells and the
MAD2B-7 and MAD2B-9 cell lines were analyzed for MAD2B by immu-
noblot using an antiserum specific to MAD2B. The Myc-MAD2B protein
is slightly larger than the endogenous MAD2 protein.
Fig. 8. Human MAD2B antagonizes the cell lysis-promoting property of ADP in wild-type adenovirus-infected A549 cells. A549 cells or the MAD2B-7 stable
cell line expressing MAD2B was infected with rec700 (wild-type) or pm734.1 (ADP-minus) at 25 pfu/cell. Cell lysis was determined by release of lactate
dehydrogenase from the cells into the medium (A) and by trypan blue exclusion assay (B). For Panel A, the standard deviation of the mean for each data
point was less than 0.05, and so the error bars cannot be seen. For Panel B, 400–600 cells were examined for trypan blue exclusion for each data point.
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contrast, with pm734.1 infected cells, no significant differ-
ence in cell lysis was observed.
Results similar to those obtained in the LDH release and
the trypan blue exclusion assays with the MAD2B-7 cell
line were obtained with another stable MAD2B cell line,
MAD2B-9 (data not shown), indicating that neither cell line
is unique in being relatively resistant to Ad-induced cell
lysis.
Altogether, these results support the hypothesis that ex-
pression of MAD2B counteracts the ADP cell lysis-promot-
ing function and that the ADP–MAD2B interaction is bio-
logically relevant.
Discussion
We have shown that human MAD2B is a cellular binding
partner for Ad2-coded ADP. The interaction was first es-
tablished by use of the yeast two-hybrid system and then
confirmed by in vitro and in vivo binding assays. The
expression of MAD2B in stably transfected A549 cells
antagonized the cell lysis-promoting property of ADP in
wild-type Ad infection, suggesting the biological relevance
of the MAD2B–ADP interaction.
The binding site for MAD2B in ADP was located using
the two-hybrid system in a 40-aa residue region of the ADP
C-terminal cytoplasmic/nucleoplasmic domain. As part of a
larger study, a series of virus mutants with lesions in the adp
gene has been analyzed with respect to the intracellular
localization of ADP and the ability of ADP to induce cell
lysis (Tollefson et al., 2003). This study included mutants
with the ADP deletions shown in Fig. 1C that do not bind
MAD2B in the yeast two-hybrid assay. The interpretation of
the phenotypes is not straightforward because the deletions
affect the intracellular membrane localization and in some
cases the level of expression of ADP. In trypan blue exclu-
sion and lactate dehydrogenase release assays of mutant
virus-infected A549 cells (similar to the assays in Fig. 8), all
mutants showed a slower rate of cell lysis as compared to
the wild-type rec700 virus. The 63–70 (virus mutant
dl715.1) and 81–88 (dl717) mutants had a marked but not
completely defective phenotype, the 76–89 (dl715) mu-
tant had an intermediate phenotype, and the 71–94 (dl714)
and 79–101 (dl716) mutants had a less severe phenotype.
These results may indicate that binding of ADP to MAD2B
is important but not essential for ADP to induce cell lysis.
However, it is important to bear in mind that the mutant
ADP proteins may interact with MAD2B in infected cells
even if they do not bind to MAD2B in the yeast two-hybrid
system in which they are totally out of context.
MAD2B (also referred to as MAD2L2 or hREV7) was
originally identified as a member of the family of MAD
(mitotic arrest deficiency) and BUB (budding uninhibited
by benzimidazole) genes, implicated in the mitotic check-
point control mechanism (Cahill et al., 1999; Pfleger et al.,
2001; Chen and Fang, 2001). Cell progression from meta-
phase to anaphase and exit from mitosis require the degra-
dation of key cell cycle regulatory proteins, including mi-
totic cyclins and securin (Glotzer et al., 1991; Zachariae and
Nasmyth, 1999). This degradation is mediated by the
anaphase-promoting complex (APC) through ubiquitination
of the proteins. APC is a ubiquitin ligase that is activated by
CDC20 and CDH1 (Fang et al., 1998a; Kramer et al., 2000;
Visintin et al., 1997) and inhibited by MAD2 and MAD2B
(Pfleger et al., 2001; Chen and Fang, 2001) in a timed
fashion. MAD2 plays a clearly defined role in the spindle
assembly checkpoint by directly associating with CDC20
and inhibiting activation of APC by CDC20 (Fang et al.,
1998b; Kim et al., 1998; Hwang et al., 1998); MAD2
thereby prevents degradation of cell cycle regulatory pro-
teins, which will arrest cells in metaphase. MAD2 inhibits
the initiation of anaphase when the sister chromatids have
not been aligned at the metaphase plate and the spindle
assembly checkpoint is activated.
A definitive role for MAD2B in the cell cycle is not
clear. It has been shown that MAD2B associates with both
CDH1 and CDC20 and inhibits activation of the APC by
CDH1 and CDC20 (Pfleger et al., 2001; Chen and Fang,
2001). CDH1 assembles with the APC later in anaphase and
remains bound to the APC throughout the G1-phase of the
cell cycle, suggesting that MAD2B may play a related role
in the late stages of mitosis, such as exit from mitosis.
MAD2B may also control the accumulation of other factors
promoting S-phase and regulating DNA replication. It has
been shown that cells continuously expressing CDH1 have
constitutive APC activity (Sørensen et al., 2000). Although
MAD2B is projected as a cell cycle checkpoint protein, no
growth deficits were observed in the cell clones overex-
pressing the Myc-tagged MAD2B in the growth curve study
under normal growth conditions (data not shown). A sepa-
rate study (Murakumo et al., 2000) also reported that over-
expression of hREV7 (also named MAD2B) did not affect
the cell cycle. In their study, the EcR293 cell lines overex-
press hREV7 under the control of the ecdysone promoter; at
0, 24, 48, and 72 h after induction with ecdysone, the
fractions of cells in G1, S, and G2/M phases were deter-
mined by FACS analysis. The cell lines overexpressing
hREV7 did not display any alterations of the cell cycle.
Taken together, cells overexpressing MAD2B have not af-
fected cell cycle progression under normal growth condi-
tions. We have not eliminated the possibility of an effect of
MAD2B overexpression on damage-induced M-phase ar-
rest.
In addition to a role for MAD2B in the cell cycle con-
trols, MAD2B, also referred to as hREV7, was found to
interact with both hREV1 and hREV3 (Murakumo et al.,
2000, 2001). The yeast homologs of REV1 and REV3
promote error-prone “translesion” DNA synthesis (DNA
synthesis across gaps in DNA), suggesting the possibility
that hREV7 might play an important role in regulating the
enzymatic activities of hREV1 and hREV3 in response to
DNA damage. Although the biological function of hREV7
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in this process remains unknown, hREV7 may facilitate the
polymerase activity of hREV3, or perhaps modulate the
terminal deoxycytidyl transferase activity of hREV1. In-
deed, it has been proposed that hREV7 may act as an
adapter between DNA repair and the spindle assembly
checkpoint (Murakumo et al., 2000). However the activity
of hREV7-associated hREV1 and hREV3 has not been
measured directly, and therefore, the effect of this associa-
tion on the hREV1 and hREV3 activity remains to be
determined.
Finally, it has been shown that MAD2B interacts with
MDC9, a member of the metalloprotease–disintegrin family
(Nelson et al., 1999). This family, which now contains over
28 members, is composed of transmembrane glycoproteins
with several domains including a pro domain, metallopro-
tease domain, disintegrin domain, cysteine-rich domain,
transmembrane domain, and cytoplasmic tail. The protein
family has been implicated in a number of cellular pro-
cesses, including a role in fertilization (Myles et al., 1994;
Blobel et al., 1992), myoblast fusion (Yagami-Hiromasa et
al., 1995), and ectodomain processing of cytokines (Black
et al., 1997; Moss et al., 1997). Besides their role as met-
alloproteases, the disintegrin domains are thought to medi-
ate cell–cell interaction through integrin receptors. The dis-
integrin domain of MDC15 (also named Adam15) interacts
with the integrins v3 and 51 (Nath et al., 1999; Zhang
et al., 1998). The disintegrin domain of Adam2 interacts
with the integrin 61 (Almeida et al., 1995; Chen and
Sampson, 1999; Bigler et al., 2000), and the disintegrin
domain of MDC9 interacts with the integrins 31, v5,
and 61 (Mahimkar et al., 2000; Zhou et al., 2001; Nath et
al., 2000). Cells overexpressing the MDC9 disintegrin do-
main round up, lose cell–cell and cell– contact, and fre-
quently detach from the matrix (Mahimkar et al., 2000).
Nath et al. (2000) and Zhou et al. (2001) also demonstrated
that MDC9 mediates cell adhesion; i.e., cells plated onto
wells precoated with the MDC9 disintegrin domain dis-
played a rounded morphology and increased motility. All
these data raise the question of whether the MAD2B–
MDC9 interaction has an effect on cell–cell and cell–matrix
interaction and whether the interaction of ADP with
MAD2B has an effect on either disrupting or promoting
cell–cell interaction.
Taken together, several cellular proteins have been re-
ported to interact with MAD2B. It will be interesting to
determine if the ADP–MAD2B interaction will affect the
interaction of MAD2B with other cellular proteins. Unfor-
tunately, the availability of the reagents to explore these
experiments is limited.
In summary, we have identified human MAD2B as a
cellular binding partner for ADP and have provided evi-
dence that the ADP–MAD2B interaction is biologically
relevant. Much more work is required to confirm this rele-
vance, but these data could be a starting point to understand
how ADP functions. ADP may affect virus replication and
facilitate cell lysis and Ad spread by somehow modifying
the ability of MAD2B to control mitosis and other aspects
of the cell cycle, to promote error-prone DNA synthesis, or
to mediate cell–cell interactions. MAD2B could be impor-
tant for ADP function directly, or it may affect it indirectly,
e.g., by affecting the intracellular localization of ADP.
Materials and methods
Cells and viruses
COS7 cells and human A549 cells were grown in Dul-
becco’s modified Eagle’s medium (DMEM) containing
10% fetal bovine serum (FBS). The stable MAD2B cell
lines were made by transfection of A549 cells with
pCDNA3.1(-)/myc-MAD2B, a plasmid that contains the
full-length MAD2B ORF with a Myc tag at the C-terminus,
plus the neomycin-resistance gene. The stable transfectant
cell clones were selected with 1 mg/ml of G418 and iden-
tified by Western blot and immunofluorescence analysis of
Myc-MAD2B. The cell clones MAD2B-7 and MAD2B-9
were chosen for further analysis.
The viruses used in this study were rec700 and pm734.1.
rec700 is an Ad5–Ad2–Ad5 recombinant consisting of the
Ad5 EcoRI A (map position 0–76), Ad2 EcoRI D (map
position 76–83), and Ad5 EcoRI B (map position 83–100)
fragments (Wold et al., 1986). Mutant pm734.1 has Met-1
and Met-41 in ADP mutated to Leu so that ADP would
initiate at Met-49. ADP from mutant pm734.1 was not
detectable by immunoprecipitation (A.E. Tollefson and
W.S.M. Wold, unpublished results).
Expression vectors
DNA fragments coding for various segments of the Ad2
E3-ADP protein were generated by polymerase chain reac-
tion (PCR) from pED, a plasmid with the Ad2 EcoRI D
fragment (position 76–83 map unit). The segments in-
cluded the full-length ADP ORF, the NH2-terminal side of
the transmembrane domain to the COOH terminus (aa 41–
101), and the cytoplasmic/nucleoplasmic domain (aa 61–
101). Also generated were deletions and mutations in the
cytoplasmic/nucleoplasmic domain (Fig. 1C). Primers were
designed such that the resulting fragments contained a 5
BamHI restriction site and a 3 stop codon and XhoI site.
These fragments were cloned in-frame to the Gal4 DNA-
binding domain of the pGBT9 vector (Clonetech) for yeast
two-hybrid analysis or into the pRsetC vector (Invitrogen,
San Diego, CA) for expression of the His6–ADP fusion
protein for in vitro transcription and translation. The ADP
mammalian expression vector pMT2-ADP was constructed
by inserting the full length ADP ORF into the pMT2 vector
at a unique EcoRI site by PCR. For MAD2B, the entire
codon sequence of MAD2B amplified by PCR was inserted
into the pGEX-4T2 vector (Pharmacia) at EcoRI/XhoI sites
and the pFlag-CMV2 vector (Sigma, St. Louis, MO) at
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EcoRI/SalI sites to produce plasmids encoding glutathione
S-transferase (GST)-tagged and FLAG-tagged MAD2B, re-
spectively. COOH-terminal Myc-tagged MAD2B was con-
structed by inserting the MAD2B cDNA in-frame into the
pCDNA3.1(-)/Myc-His A vector (Introgen, Carlsbad, CA)
at EcoRI/HindIII sites by PCR. The fidelity of all of the
constructs was confirmed by DNA sequencing.
Yeast two-hybrid screening
The pGBT9–ADPc (aa 61–101) construct was simulta-
neously transformed with the Gal4 activation domain-
tagged HeLa or human fetal brain cDNA library into Sac-
charomyces cerevisiae Y153 strain in the presence of 25
mM 3-aminotriazole according to the manufacturer’s pro-
tocol. His3 gene expression was assessed by growth on
histidine-free media, whereas LacZ gene expression was
determined with an X-gal filter assay. Clones were subse-
quently isolated from yeast and transferred into E. coli
HB101 bacteria, and DNA was sequenced on an automatic
DNA sequencer (373, Applied Biosystems, Inc). The spec-
ificity of the interactions was determined by cotransforming
potential positive plamids with various heterologous protein
baits.
Antibodies
Polyclonal anti-ADP peptide antibodies p63–77 and
p87–101 were described previously (Tollefson et al., 1992).
These are rabbit antisera raised against peptides correspond-
ing to aa 63–77 and 87–101 in Ad2 ADP, respectively. The
anti-FLAG M2 monoclonal antibody was purchased from
Sigma (St. Louis, MO). The anti-Myc monoclonal and poly-
clonal antibodies were purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA).
To generate polyclonal anti-MAD2B antibody, a GST–
MAD2B fusion protein was expressed and purified from E.
coli BL2DE3 according to the manufacturer’s protocol
(Pharmacia) and used to immunize rabbits.
Northern blot analysis
Human multiple tissue Northern blot and human cancer
cell line Northern blot were purchased from Clontech and
were hybridized with MAD2B cDNA or human -actin
cDNA probe labeled with 32P using the random priming
method. The probes were hybridized with the blots under
high-stringency conditions using ExpressHyb in accordance
with Clontech’s recommendations.
In vitro protein–protein interaction
GST fusion proteins were expressed in E. coli strain
Bl21DE3 and were immobilized on glutathione–agarose
beads (Pharmacia). The wild-type and truncated Ad2 ADP
were synthesized by in vitro transcription–translation in a
rabbit reticulocyte lysate in the presence of [35S]methi-
onine/cystine mixture according to the manufacturer’s pro-
tocol (Promega). Briefly, a 25-l slurry of glutathione–
agarose beads containing 10 g of GST protein or GST–
MAD2B fusion protein were preincubated for 1 h on ice in
a final volume of 250 l of a binding buffer (10 mM
HEPES, pH 7.4, 142.5 mM NaC1, 1 mM EDTA, 1 mM
dithiothreitol (DTT), 0.25% Nonidet P-40 (NP-40), 2 mM
phenylmethylsulfonyl fluoride (PMSF), 10 g/ml leupeptin,
10 g/ml aprotinin, 1 mg/ml bovine serum albumin). Sub-
sequently, an aliquot of radiolabeled ADP was added to the
mixture and incubated for 2 h at 4°C with rotation. The
beads were washed five times with the ice-cold binding
buffer. The complexes were separated on SDS–polyacryl-
amide gels (SDS–PAGE), which were then subjected to
PhosphorImager analysis.
Coimmunoprecipitation
COS7 cells were grown in 60-mm-diameter dishes over-
night and were transfected with 6 g each of pMT2-ADP
and pCDNA3.1()/Myc-MAD2B using the DEAE–Dex-
tran method. At 48 h posttransfection, cells were washed
twice with 1X PBS and disrupted with ice-cold NP-40 lysis
buffer (25 mM Tris, pH 7.4, 150 mM NaC1, 1 mM EDTA,
0.2% NP-40, 1 mM DTT, 2 mM PMSF, 10 g/ml leupeptin,
10 g/ml aprotinin). The lysate was cleared by centrifuga-
tion at maximum speed in a microcentrifuge, and 5 l of
polyclonal anti-ADP antibody p87–101 was added. After
rotation for 4 h at 4°C, 50 l of 50% (vol/vol) protein A
beads (Sigma) was added to the lysate and rotated for 2 h.
The beads were washed five times with the lysis buffer and
resuspended in 30 l of Laemmli buffer. After being boiled,
the samples were subjected to SDS–PAGE. The gel was
transferred to PVDF membranes (Immobilon-P, Millipore,
Bedford, MA). The blot was preblocked with TBS–Tween
20 containing 5% nonfat dry milk and subsequently incu-
bated with anti-Myc polyclonal antibody (1:1000) in TBS–
Tween 20 containing 5% milk for 1.5 h followed by HRP-
conjugated goat anti-rabbit IgG (1:4000, Cappel/ICN) for
an additional 1 h. The membrane was washed four times in
TBS–Tween 20 for 5 min following each antibody incuba-
tion step. Detection was conducted using chemilumines-
cence reagents as described by the supplier (Kirkegaard &
Perry Laboratories, Inc., Gaitherberg, MD).
Trypan blue exclusion assay and lactate dehydrogenase
assay for cell viability
A549 parental cells, or MAD2B-7 or MAD2B-9 stably
transfected cells (5  105 cells per well in a six-well plate),
were infected with rec700 or pm734.1 at 25 pfu per cell in
1 ml of serum-free DMEM. At 1 hpi, 1.5 ml of DMEM
(10% FCS) was added to each well. At the indicated time
points, trypan blue exclusion assay and LDH release assay
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(Promega, Madison, WI) were performed in triplicate as
previously described (Tollefson et al., 1996a).
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